NCT00884273 Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients Status COMPLETED Phase PHASE3
NCT00882232 Cross-linked Hyaluronan Gel Reduces Rectal Toxicity Due to Radiation Therapy for Prostate Cancer Status COMPLETED Phase PHASE1
NCT00879619 Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients Status TERMINATED Phase PHASE1/PHASE2
NCT00878436 Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration Status COMPLETED Phase PHASE1/PHASE2
NCT00877617 Quality of Life in Men With High Risk Localized Prostate Cancer Status WITHDRAWN Phase N/A
NCT00874211 S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Status COMPLETED Phase N/A
NCT00872157 BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With Bone Mets Status COMPLETED Phase PHASE1
NCT00870714 Neoadjuvant Therapy With Docetaxel and Ketoconazole in Patients With High-Risk Prostate Cancer: A Pilot Study Status UNKNOWN Phase NA
NCT00869739 Helping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate Cancer Status COMPLETED Phase NA
NCT00868868 Pedometer and Exercise Study in Prostate Cancer Patients With Hormonal Therapy Status UNKNOWN Phase N/A
NCT00866554 Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy Status COMPLETED Phase PHASE2
NCT00861471 Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00860158 Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer Status TERMINATED Phase PHASE2
NCT00859781 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00859768 The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients Status COMPLETED Phase NA